Registered entities
HERANTIS PHARMA OYJ
Reg. No. 926458906Norway
Innovation
4 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 168 times.
| Year | Filings |
|---|---|
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
Social engagement
Social engagement: 6K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 1 | 13% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 2 | 25% |
Recent activity
25 Jun 2026
Leadership hire
Chief Medical Officer
28 May 2026
Event
Live webcast on Phase 2a proof-of-concept efficacy study of HER-096